Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro

J Virol. 2005 Apr;79(7):4506-9. doi: 10.1128/JVI.79.7.4506-4509.2005.

Abstract

The Epstein-Barr virus (EBV) nuclear antigen 3B (EBNA-3B) is considered nonessential for EBV-mediated B-cell growth transformation in vitro based on three virus isolates with EBNA-3B mutations. Two of these isolates could potentially express truncated EBNA-3B products, and, similarly, we now show that the third isolate, IB4, has a point mutation and in-frame deletion of 263 amino acids. In order to test whether a virus with EBNA-3B completely deleted can immortalize B-cell growth, we first cloned the EBV genome as a bacterial artificial chromosome (BAC) and showed that the BAC-derived virus was B-cell immortalization competent. Deletion of the entire EBNA-3B open reading frame from the EBV BAC had no adverse impact on growth of EBV-immortalized B cells, providing formal proof that EBNA-3B is not essential for EBV-mediated B-cell growth transformation in vitro.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • B-Lymphocytes / physiology*
  • B-Lymphocytes / virology*
  • Cell Line
  • Cell Proliferation
  • Cell Transformation, Viral*
  • Epstein-Barr Virus Nuclear Antigens / genetics*
  • Gene Deletion
  • Herpesvirus 4, Human / genetics*
  • Humans
  • In Vitro Techniques
  • Molecular Sequence Data
  • Point Mutation

Substances

  • EBNA-3B antigen
  • Epstein-Barr Virus Nuclear Antigens